Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Regencell Bioscience Holdings Ltd RGC

Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.


NDAQ:RGC - Post by User

Post by IamCardiBon Aug 03, 2022 7:48am
47 Views
Post# 34867479

Is RGC the next HKD

Is RGC the next HKD

A recent stock that has gone to the moon since its mid-July 2022 IPO is a company founded by Mr. Li Ka-Shing’s Cheung Kong Group and Hutchison Whampoa in 2003, AMTD Digital (NYSE:HKD). HKD’s IPO price was $7.80 and has gained over 9,000% since, closing at $742.00 on August 1, 2022.

* as of this post, HKD had more than 21,000% gains since its IPO. 

 

RGC and HKD have some similarities between them. 

  1. They are both founded by individuals who believe in philanthropy and giving back to society.
  2. Listed in mid-July and is based in Hong Kong.
  3. RGC is the top performing 2021 IPO (as at 2 Aug 2021).
  4. HKD is the top performing 2022 IPO (as at 2 Aug 2021).
  5. Has a low float.


Although RGC is the #1 performer of 2021 IPOs, this pales in comparison with the current performance of HKD. Only time will tell if RGC achieves similar heights, but the similarities seem interesting. 

https://www.benzinga.com/amp/content/28316977

<< Previous
Bullboard Posts
Next >>